Gemini Therapeutics, Inc.
Gemini Therapeutics, Inc. (GMTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GMTX · as of Jun 9, 2026
Key Statistics
Explore Gemini Therapeutics, Inc. Data
gmtx stock data · financialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
gmtx competitorsGMTX
ALLK
ANGN
ANPC
ELEV
FRLNStock Performance
Full HistoryAbout Gemini Therapeutics, Inc.
Gemini Therapeutics, Inc. operates as a clinical-stage precision medicine enterprise, dedicated to crafting various therapeutic solutions for age-related macular degeneration (AMD) with a genetic foun…
what is gemini therapeutics, inc. · gmtx stock overview · gemini therapeutics, inc. company profile · who is gemini therapeutics, inc. ceo · gmtx NASDAQ · gemini therapeutics, inc. headquarters · gemini therapeutics, inc. business segments
About Stock Overview & Key Data
Gemini Therapeutics, Inc. (GMTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 12, 2020. As of the latest trading session, GMTX stock price is $1.35, with a market capitalization of $25.5M. The stock has returned -91.82% over the past 12 months and -92.48% year-to-date.
Frequently Asked Questions
As of the latest trading session, Gemini Therapeutics, Inc. (GMTX) stock price is $1.35. The stock is traded on NASDAQ under the ticker symbol GMTX. The 52-week range is $1.35 – $24.70.